- Home
- MLCO vs LNTH Comparison
MLCO vs LNTH Comparison
Compare MLCO & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLCO
- LNTH
- Stock Information
- Founded
- MLCO 2004
- LNTH 1956
- Country
- MLCO Hong Kong
- LNTH United States
- Employees
- MLCO N/A
- LNTH N/A
- Industry
- MLCO Hotels/Resorts
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MLCO Consumer Discretionary
- LNTH Health Care
- Exchange
- MLCO Nasdaq
- LNTH Nasdaq
- Market Cap
- MLCO 3.7B
- LNTH 3.6B
- IPO Year
- MLCO 2006
- LNTH 2015
- Fundamental
- Price
- MLCO $8.62
- LNTH $53.77
- Analyst Decision
- MLCO Buy
- LNTH Strong Buy
- Analyst Count
- MLCO 5
- LNTH 6
- Target Price
- MLCO $9.78
- LNTH $105.50
- AVG Volume (30 Days)
- MLCO 2.7M
- LNTH 2.1M
- Earning Date
- MLCO 07-31-2025
- LNTH 08-06-2025
- Dividend Yield
- MLCO N/A
- LNTH N/A
- EPS Growth
- MLCO N/A
- LNTH N/A
- EPS
- MLCO 0.14
- LNTH 3.77
- Revenue
- MLCO $4,926,670,000.00
- LNTH $1,520,653,000.00
- Revenue This Year
- MLCO $9.63
- LNTH $4.57
- Revenue Next Year
- MLCO $3.32
- LNTH $9.41
- P/E Ratio
- MLCO $62.88
- LNTH $14.44
- Revenue Growth
- MLCO 12.41
- LNTH 5.75
- 52 Week Low
- MLCO $4.55
- LNTH $47.25
- 52 Week High
- MLCO $9.17
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- MLCO 51.76
- LNTH 29.17
- Support Level
- MLCO $8.41
- LNTH $51.40
- Resistance Level
- MLCO $8.84
- LNTH $57.21
- Average True Range (ATR)
- MLCO 0.25
- LNTH 2.21
- MACD
- MLCO -0.09
- LNTH -1.03
- Stochastic Oscillator
- MLCO 43.63
- LNTH 27.75
About MLCO Melco Resorts & Entertainment Limited
Melco Resorts and Entertainment Ltd is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 81% from Macao with the rest largely from the Philippines as of 2024.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.